OakChart

Airsculpt Technologies Inc

AIRSHealthcare·Medical Care Facilities·USA·Micro·NASD·Nov 11 • 3:59 PM ET

0.8055+0.0350 (4.54%)
2026-11-11 23:30 CET
Market cap
56.96 USD m
Revenue, TTM
147.68 USD m
Net income, TTM
-9.40 USD m
Free cash flow, TTM
-2.54 USD m
EPS diluted, TTM
-0.13
P/E
-
Compare

Price

AIRS against its 20, 50 and 200-day averages
2050200miss
2.004.006.005.6M11.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AIRSclose 0.8120-day 1.2750-day 1.76200-day 3.060.8152w low

87.5% under the 52-week high of 6.42 on 11 Nov 2025. 52-week low 0.52 on 6 Nov 2026. Last 15 sessions, 262.4% high to low

Volume 1.60× normal · the line is the 50-bar volume average

Profile

AIRS
52-week range, 5% of the way up
0.526.42

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

IndexRUT
Employees363
IPOOct 29, 2021
Beta2.34
ATR, 14d0.20
Rel volume1.60
Short float29.92%
Insider own85.38%
Inst own19.23%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap59.55M
Enterprise Value110.36M
Income-9.40M
Sales147.68M
Book/sh1.43
Cash/sh0.21
Dividend Est.-
Dividend TTM-
Dividend Ex-DateAug 25, 2022
Dividend Gr. 3/5Y- -
Payout-
Employees363
IPOOct 29, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S0.40
P/B0.56
P/C3.92
P/FCF-
EV/EBITDA13.69
EV/Sales0.75
Quick Ratio0.85
Current Ratio0.85
Debt/Eq0.62
LT Debt/Eq0.50
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.13
EPS next Y-0.13
EPS next Q-0.04
EPS this Y-230.00%
EPS next Y21.21%
EPS next 5Y-
EPS past 3/5Y9.87% -
Sales past 3/5Y-3.47% 19.32%
EPS Y/Y TTM56.57%
Sales Y/Y TTM-6.27%
EPS Q/Q35.10%
Sales Q/Q-8.71%
EarningsNov 06 BMO
EPS/Sales Surpr.-166.67% -6.95%

Ownership

Insider Own85.38%
Insider Trans0.00%
Inst Own19.23%
Inst Trans-5.96%
ROA-5.03%
ROE-10.00%
ROIC-5.93%
Gross Margin52.14%
Oper. Margin-2.63%
Profit Margin-6.36%
SMA20-36.77%
SMA50-54.33%
SMA200-73.63%
Trades-

Technical

Shs Outstand73.93M
Shs Float10.81M
Short Float29.92%
Short Ratio2.83
Short Interest3.23M
52W High6.42 -87.45%
52W Low0.52 56.26%
Volatility35.09% 16.33%
ATR (14)0.20
RSI (14)33.76
Beta2.34
Rel Volume1.60
Avg Volume1.14M
Volume1,829,624

Performance

Perf Week-52.62%
Perf Month-50.28%
Perf Quarter-76.17%
Perf Half Y-82.71%
Perf YTD-59.32%
Perf Year-86.04%
Perf 3Y-85.56%
Perf 5Y-94.42%
Perf 10Y-
Recom1.80
Target Price2.50
Prev Close0.77
Price0.81
Change %4.54%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Oct 29, 2026InitiatedLLake StreetBuy$3+272.4%
Oct 17, 2024InitiatedBBTIG ResearchNeutral
May 14, 2024DowngradeLLeerink PartnersOutperform → Market Perform$8.25 → $5+520.7%
Nov 11, 2022DowngradePPiper SandlerOverweight → Neutral$4+396.6%
Jun 16, 2022DowngradeMMorgan StanleyOverweight → Equal-Weight$17 → $8.50+955.2%
Nov 23, 2021InitiatedSSVB LeerinkOutperform$26+3,127.8%
Nov 23, 2021InitiatedRRaymond JamesOutperform$18+2,134.6%
Nov 23, 2021InitiatedPPiper SandlerOverweight$22+2,631.2%
Nov 23, 2021InitiatedMMorgan StanleyOverweight$17+2,010.5%

Peers

Mkt cap
TickerCompanyMkt cap
APYXApyx Medical Corp126.37M
BTMDbiote Corp60.74M
JYNTJoint Corp93.09M
WWWW International Inc130.49M
INMDInmode Ltd790.08M
SGRYSurgery Partners Inc3.49B
ESTAEstablishment Labs Holdings Inc2.11B
SBCSBC Medical Group Holdings Inc538.92M
EOLSEvolus Inc491.11M
SKINSkinHealth Systems Inc109.07M

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Chernett Jorey10% OwnerApr 17 '26Buy2.5440,000101,6007,053,761Apr 20 09:16 AM
Chernett Jorey10% OwnerApr 14 '26Buy2.6020,00052,0007,013,761Apr 15 09:35 AM
Chernett Jorey10% OwnerApr 07 '26Buy2.9360,000175,8006,993,761Apr 08 09:09 AM
Chernett Jorey10% OwnerApr 03 '26Buy2.8290,000253,8006,933,761Apr 06 09:34 AM
Chernett Jorey10% OwnerMar 23 '26Buy2.9150,000145,5006,843,761Mar 25 01:43 PM
Chernett Jorey10% OwnerMar 20 '26Buy2.7740,000110,8006,793,761Mar 23 09:33 AM
Chernett Jorey10% OwnerMar 19 '26Buy2.6477,702205,1336,753,761Mar 20 09:33 AM
Chernett Jorey10% OwnerMar 17 '26Buy2.5683,000212,4806,676,059Mar 18 10:36 AM
Chernett Jorey10% OwnerMar 16 '26Buy2.43105,848257,2116,592,059Mar 16 06:43 PM
Chernett Jorey10% OwnerMar 11 '26Buy2.1588,000189,2006,486,211Mar 11 05:30 PM
Chernett Jorey10% OwnerMar 06 '26Buy2.0045,60091,2006,398,211Mar 09 08:40 AM
Chernett Jorey10% OwnerMar 03 '26Buy1.7180,000136,8006,322,611Mar 04 06:58 PM
Chernett Jorey10% OwnerMar 04 '26Buy1.8730,00056,1006,352,611Mar 04 06:58 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
IWNiShares Russell 2000 Value ETFAUM: 14.10B
IWCiShares Micro-Cap ETFAUM: 1.22B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B

News

latest 14 of 100
  • AirSculpt Technologies Announces First-Ever Nationwide Open House Event, "The Gift of Body Confidence" (GlobeNewswire)
  • AirSculpt Technologies Announces Participation in the A.G.P. Virtual Consumer Showcase (GlobeNewswire) +26.47% +14.11%
  • AirSculpt Technologies Cuts 2026 Guidance as Q3 Revenue Falls 8.7% to $31.9 Million (InvestorsHub) -62.92%
  • AirSculpt's Turnaround Reverses: Same-Center Demand Slumps, EBITDA Nearly Vanishes, And Guidance Is Cut Again (Earnings Whispers)
  • AirSculpt Technologies Reports Third Quarter Fiscal 2026 Results (GlobeNewswire)
  • AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 Results (GlobeNewswire)
  • Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. (MarketWatch)
  • AirSculpt Technologies Inc (AIRS) (Q2 2026) Earnings Call Highlights: Strategic Investments ... (GuruFocus.com) +16.91%
  • AirSculpt Technologies shares plunge 13% after revenue miss and weaker EBITDA outlook (InvestorsHub) -45.11%
  • AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results (GlobeNewswire)
  • AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results (GlobeNewswire)
  • AirSculpt Technologies Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
  • AirSculpt Technologies Reports First Quarter Fiscal 2026 Results (GlobeNewswire) +11.56%
  • AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results (GlobeNewswire) +23.88%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-06-0.080-0.030-0.10031.9434.332
2026Q22026-08-100.0100.015-0.01642.9044.142
2026Q12026-05-08-0.010-0.020-0.03539.3939.202
2025Q42026-04-02-0.020-0.0250.02033.4434.502
2025Q32025-11-07-0.040-0.020-0.15234.9939.803
2025Q22025-08-010.0200.007-0.01044.0145.453
2025Q12025-05-02-0.020-0.033-0.04939.3739.403
2024Q42025-03-14-0.0800.017-0.08739.1843.383
2024Q32024-11-08-0.020-0.003-0.10542.5541.734
2024Q22024-08-090.0900.130-0.05651.0055.262
2024Q12024-05-100.0300.0800.10347.6249.802
2023Q42024-02-270.0100.105-0.08047.6148.072
2023Q32023-11-090.0500.087-0.02946.7944.613
2023Q22023-08-110.1300.1500.03155.7054.702
2023Q12023-05-120.1000.1300.00045.8142.953
2022Q42023-03-100.070-0.030-0.12840.7041.092

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY0.1400.320-0.007133.32130.21
2022FY0.3700.405-0.264168.79169.14
2023FY0.2800.375-0.079195.92196.38
2024FY0.0200.113-0.139180.35184.56
2025FY-0.050-0.149-0.190151.82152.85
2026FY--0.165--146.1
2027FY--0.130--148.26
2028FY--0.120--148.06

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0950431.4529.8034.80
2026Q4S2026-11-0650332.3130.7034.80
2026Q4S2026-10-2850034.4634.1134.80
2026Q4S2026-10-0240034.3834.1134.80
2026Q4S2026-08-1030034.2434.1134.40
2026Q4S2026-07-2730034.2734.1034.60
2026Q4S2026-07-2230134.2734.1034.60
2026Q4S2026-07-2030234.2734.1034.60
2026Q4S2026-05-1320234.3534.1034.60
2026Q4S2026-05-0820235.5534.6036.50
2026Q4S2026-04-1421136.8036.5037.10
2026Q4S2026-04-0831136.1934.9737.10
2026Q4S2026-04-0221036.0334.9737.10
2026Q4S2026-03-1220038.1636.6239.70

Estimate history

EPS, annual-0.040.136-0.007-0.264-0.079-0.139-0.193-0.1292
Period2019202020212022202320242025TTM
EPS, quarterly-0.105-0.087-0.049-0.01-0.1520.02-0.035-0.016-0.099
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual41.23662.766133.315168.794195.917180.35151.818147.68
Period2019202020212022202320242025TTM
Sales, quarterly42.54839.17839.37144.01234.99333.44239.38942.931.944
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual55.6455.6455.6456.18257.35658.36964.45673.926
Period2019202020212022202320242025MRQ
Shares, quarterly57.80958.36958.66162.43762.43764.45670.54671.51973.926
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue147.68151.82180.35195.92168.79133.3162.7741.24
Cost of Goods Sold Incl. D&A70.6874.4783.0484.2770.8451.1329.1120.45
Gross Profit76.9977.3597.31111.6597.9582.1833.6520.79
Selling, General and Administrative Excl. Other80.8777.3691.0093.5992.2851.4922.6319.25
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.88-0.016.3118.065.6730.6911.031.54
Interest Expense4.976.086.256.496.754.892.462.88
Unusual Expense3.1011.547.898.7910.0714.930.990.87
Net Income Before Taxes-11.95-17.64-7.833.00-11.3010.887.58-2.21
Income Taxes-2.55-5.970.197.483.380.330.000.00
Consolidated Net Income-9.40-11.67-8.02-4.48-14.68-0.397.58-2.21
Net Income From Continuing Operations-9.40-11.67-8.02-4.48-14.68-0.397.58-2.21
Net Income-9.40-11.67-8.02-4.48-14.68-0.397.58-2.21
EPS (Recurring)-0.10-0.06-0.040.03-0.140.180.15-0.03
EPS (Basic, Before Extraordinaries)-0.13-0.19-0.14-0.08-0.26-0.010.14-0.04
EPS (Diluted)-0.13-0.19-0.14-0.08-0.26-0.010.14-0.04
EBITDA8.0612.7718.2028.3113.7337.2916.676.50
Non-Operating Income (Expense)-0.000.000.000.21-0.150.000.000.00
Other After Tax Adjustments0.000.000.000.000.00-10.940.000.00
Stock Option Compensation Expense-1.842.9714.4023.275.250.240.25
Price To Sales Ratio0.860.791.662.171.227.17--
Gross Margin52.1450.9553.9656.9958.0361.6453.6250.41
Operating Margin-2.63-0.013.509.223.3623.0217.573.72
Net Margin-6.36-7.68-4.45-2.29-8.70-0.2912.07-5.36
Shares Outstanding73.9364.4658.3757.3656.1855.6455.6455.64
Market Capitalization56.9656.96300.41425.32205.87912.17954.63-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue31.9442.9039.3933.4434.9944.0139.3739.18
Cost of Goods Sold Incl. D&A15.8219.5118.6116.7518.0820.4519.1919.94
Gross Profit16.1323.3920.7816.6916.9123.5720.1819.24
Selling, General and Administrative Excl. Other20.2323.1021.6315.9118.2122.3320.9122.72
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.100.29-0.850.78-1.301.24-0.73-3.48
Interest Expense1.241.041.201.481.411.561.621.61
Unusual Expense0.040.320.951.788.450.340.860.64
Net Income Before Taxes-5.38-1.21-2.86-2.49-11.16-0.78-3.21-5.74
Income Taxes1.79-0.10-0.47-3.77-1.65-0.18-0.37-0.71
Consolidated Net Income-7.17-1.11-2.401.28-9.51-0.59-2.85-5.03
Net Income From Continuing Operations-7.17-1.11-2.401.28-9.51-0.59-2.85-5.03
Net Income-7.17-1.11-2.401.28-9.51-0.59-2.85-5.03
EPS (Recurring)-0.10-0.01-0.020.04-0.06-0.01-0.04-0.08
EPS (Basic, Before Extraordinaries)-0.10-0.02-0.030.02-0.15-0.01-0.05-0.09
EPS (Diluted)-0.10-0.02-0.030.02-0.15-0.01-0.05-0.09
EBITDA-1.203.232.173.851.914.482.52-0.28
Non-Operating Income (Expense)-0.00-0.140.140.000.00-0.110.00-0.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.870.720.47-0.891.070.981.77
Price To Sales Ratio0.862.111.290.843.181.740.791.67
Gross Margin50.4954.5352.7649.9148.3353.5451.2549.10
Operating Margin-12.840.69-2.162.32-3.722.81-1.84-8.88
Net Margin-22.45-2.59-6.093.84-27.18-1.34-7.23-12.85
Shares Outstanding73.9371.5270.5564.4662.4462.4458.6658.37
Market Capitalization56.96317.46176.70123.62500.74301.46136.77300.41

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments8.458.2310.269.6225.3510.385.13
Short Term Receivables1.503.061.942.830.000.000.00
Inventories0.000.000.000.000.000.000.00
Other Current Assets5.515.833.764.234.091.181.46
Total Current Assets15.4617.1215.9616.6829.4411.566.59
Net Property, Plant & Equipment50.2766.9154.3247.9731.7924.1616.48
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets118.57123.33128.08132.83137.59142.34147.10
Deferred Tax Assets--9.538.435.82--
Other Assets3.015.435.663.281.741.541.34
Total Assets187.30212.78213.55209.19206.37179.61171.50
Short Term Debt Incl. Current Port. of LT Debt14.7412.277.506.484.323.292.34
Accounts Payable5.376.263.923.842.671.092.11
Other Current Liabilities7.7910.438.8911.999.425.073.90
Total Current Liabilities27.9028.9520.3222.3216.419.468.35
Long Term Debt70.8198.2592.17101.1796.2646.4842.76
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities0.886.5816.3613.9110.17--
Other Liabilities0.000.820.721.020.000.000.00
Total Liabilities99.59134.59129.56138.42122.8455.9351.11
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity87.7178.1983.9970.7783.53123.68120.39
Total Shareholders Equity87.7178.1983.9970.7783.53123.68120.39
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity87.7178.1983.9970.7783.53123.68120.39
Total Liabilities & Stockholders Equity187.30212.78213.55209.19206.37179.61171.50
Book Value Per Share1.361.341.461.261.502.222.16
Tangible Book Value Per Share-0.48-0.77-0.77-1.10-0.97-0.34-0.48
Full-Time Employees363422346291240--
Price to Book Ratio0.543.645.052.8410.9811.70-
Return on Assets-5.87-3.76-2.12-7.06-0.204.32-
Return on Equity-13.97-9.89-5.79-19.03-0.386.21-
Return on Invested Capital-7.36-4.54-2.54-8.54-0.224.45-1.36
Quick Ratio0.550.590.790.751.791.220.79
Current Ratio0.550.590.790.751.791.220.79

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-9.40-11.67-8.02-4.48-14.6810.557.58-2.21
Depreciation11.9412.7811.8910.258.066.605.644.96
Other Funds (Non Cash)1.229.584.1218.2231.468.510.540.57
Funds from Operations-0.934.787.7425.3425.9725.8613.753.31
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-1.05-1.693.62-1.38-1.530.770.201.62
Cash from Operating Activities-1.973.1011.3523.9624.4526.6313.964.94
Capital Expenditures-0.56-2.40-14.01-9.92-12.92-7.12-3.69-4.44
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.56-2.40-14.01-9.92-12.92-7.12-3.69-4.44
Cash Dividends Paid0.000.00-0.25-0.46-24.32-66.86-4.62-0.28
Change in Capital Stock31.7018.760.000.000.0013.540.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock31.7018.760.000.000.0013.540.000.00
Proceedsfrom Stock Options31.7018.760.000.000.0013.540.000.00
Issuance or Reduction of Debt, Net-20.81-19.192.74-12.12-0.7648.77-0.40-0.50
Change in Long Term Debt-20.81-19.192.74-12.12-0.7648.77-0.40-0.50
Issuance of Long Term Debt0.000.005.000.0083.5049.602.500.00
Reduction of Long Term Debt-20.81-19.19-2.26-12.12-84.26-0.84-2.90-0.50
Net Financing Active Other Cash Flow1.42-0.06-1.86-0.80-2.180.000.000.00
Other Financing Activities Uses1.42-0.06-1.86-0.80-2.180.000.000.00
Cash from Financing Activities12.31-0.480.63-13.39-27.26-4.55-5.02-0.78
Net Change in Cash9.780.21-2.030.65-15.7314.975.25-0.28
Free Cash Flow-2.540.69-2.6614.0411.5319.5210.270.50
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow-172.97-31.33----
Deferred Taxes & Investment Tax Credit--5.91-0.251.341.130.210.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments15.1818.8216.698.455.418.19
Short Term Receivables1.732.361.971.503.461.80
Inventories0.000.000.000.000.000.00
Other Current Assets6.136.315.675.513.356.41
Total Current Assets23.0527.5024.3315.4612.2216.41
Net Property, Plant & Equipment46.6446.5947.2650.2750.5855.37
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets115.01116.20117.39118.57119.76120.95
Other Assets3.073.003.023.013.365.64
Total Assets187.78193.28192.00187.30185.92198.37
Short Term Debt Incl. Current Port. of LT Debt13.4618.8414.2414.7413.0012.35
Accounts Payable6.427.267.465.374.463.34
Other Current Liabilities7.338.8510.787.796.7010.14
Total Current Liabilities27.2134.9532.4827.9024.1625.83
Long Term Debt52.5352.6258.3870.8173.0874.70
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities2.100.880.880.886.586.58
Other Liabilities0.000.000.000.000.000.11
Total Liabilities81.8488.4591.7499.59103.81107.21
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity105.94104.83100.2687.7182.1191.16
Total Shareholders Equity105.94104.83100.2687.7182.1191.16
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity105.94104.83100.2687.7182.1191.16
Total Liabilities & Stockholders Equity187.78193.28192.00187.30185.92198.37
Book Value Per Share1.431.471.421.361.321.46
Tangible Book Value Per Share-0.12-0.16-0.24-0.48-0.60-0.48
Full-Time Employees---363--
Price to Book Ratio0.543.172.081.515.493.66
Return on Assets-5.03-5.99-5.68-5.87-9.13-7.11
Return on Equity-10.00-11.98-12.63-13.97-21.85-16.47
Return on Invested Capital-4.53-0.71-1.510.81-6.13-0.36
Quick Ratio0.850.790.750.550.510.64
Current Ratio0.850.790.750.550.510.64

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-7.17-1.11-2.401.28-9.51-0.59
Depreciation2.902.943.023.083.223.25
Other Funds (Non Cash)1.241.050.69-1.768.401.60
Funds from Operations-1.812.881.32-3.312.104.25
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.66-4.123.950.78-2.330.73
Cash from Operating Activities-3.48-1.245.27-2.53-0.234.98
Capital Expenditures-0.23-0.23-0.05-0.06-0.18-0.27
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.23-0.23-0.05-0.06-0.18-0.27
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock7.144.9714.595.00-0.2414.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock7.144.9714.595.00-0.2414.01
Proceedsfrom Stock Options7.144.9714.595.00-0.2414.01
Issuance or Reduction of Debt, Net-7.04-1.39-11.37-1.01-0.96-15.91
Change in Long Term Debt-7.04-1.39-11.37-1.01-0.96-15.91
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-7.04-1.39-11.37-1.01-0.96-15.91
Net Financing Active Other Cash Flow-0.040.01-0.201.65-1.18-0.18
Other Financing Activities Uses-0.040.01-0.201.65-1.18-0.18
Cash from Financing Activities0.063.603.025.63-2.38-2.08
Net Change in Cash-3.642.138.243.04-2.782.64
Free Cash Flow-3.70-1.475.22-2.59-0.414.72
Price to Free Cash Flow-419.1328.30184.43224.75-

Revenue breakdown

Services-Offices & Clinics of Doctors of Medicine2024: 180.35M 2025: 151.82M
United States2024: 180.35M 2025: 151.82M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3030.69%3.2M10.5M927.30K
2026-10-1528.00%3.0M10.5M858.69K
2026-09-3028.71%3.0M10.5M785.81K
2026-09-1529.33%3.1M10.5M732.11K
2026-08-3128.72%3.0M10.5M697.18K
2026-08-1426.70%2.8M10.5M702.71K
2026-07-3140.92%2.8M6.8M826.03K
2026-07-1545.77%3.1M6.8M957.69K
2026-06-3050.06%3.4M6.8M1.15M
2026-06-1551.06%3.4M6.8M2.73M
2026-05-2926.29%3.7M14.1M2.80M
2026-05-1529.62%4.2M14.1M2.74M
2026-04-3047.42%4.4M9.2M2.58M
2026-04-15101.18%4.9M4.8M2.76M
2026-03-3181.57%5.1M6.2M2.74M
2026-03-1369.76%3.8M5.5M1.07M
2026-02-2764.72%3.6M5.5M1.01M
2026-02-1360.06%3.3M5.5M1.20M
2026-01-3037.53%3.3M8.7M1.41M
2026-01-1535.47%4.2M11.8M1.23M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.000.000.050.162.1905580.000.328-0.0060.000
call2.000.000.050.104.4979650.000.199-0.0090.000
call3.000.000.100.145.68141.000.000.172-0.0110.000
call4.000.000.750.156.81854.000.000.165-0.0120.000
call5.000.000.750.007.4020.000.000.158-0.0130.000
call6.000.000.850.007.8610.000.000.153-0.0130.000
put1.000.000.350.424.4485.000.00-0.672-0.0060.000
put2.000.851.601.2512.5060.000.00-0.798-0.0090.000
put3.001.852.601.6013.8370.000.00-0.823-0.0110.000
put4.002.703.702.2317.0860.000.00-0.835-0.0120.000
put5.004.004.600.0015.3620.000.00-0.842-0.0120.000
put6.004.705.700.0018.2240.000.00-0.847-0.0130.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-068-KCurrent report2026-11-05SEC
2026-11-068-KCurrent report2026-11-06SEC
2026-10-28SCHEDULE 13G/ASEC
2026-08-128-KCurrent report2026-08-05SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-10SCHEDULE 13G/ASEC
2026-06-01SCHEDULE 13GSEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-148-KCurrent report2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-088-KCurrent report2026-05-08SEC
2026-04-21SCHEDULE 13G/ASEC
2026-04-204Statement of changes in beneficial ownership of securities2026-04-17SEC
2026-04-16ARSAnnual report to security holders. 2025-12-31SEC
2026-04-15DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-12SEC
2026-04-154Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-104Statement of changes in beneficial ownership of securities2026-04-08SEC
2026-04-104Statement of changes in beneficial ownership of securities2026-04-08SEC
2026-04-104Statement of changes in beneficial ownership of securities2026-04-08SEC
2026-04-084Statement of changes in beneficial ownership of securities2026-04-07SEC
2026-04-068-K/A2026-04-02SEC
2026-04-0610-K/A2025-12-31SEC
2026-04-064Statement of changes in beneficial ownership of securities2026-04-03SEC
2026-04-028-KCurrent report2026-04-02SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-04583.20K400
2026-031.40M900
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Vesey Street Capital Partners, L.L.C.42.99%
THRIVENT FINANCIAL FOR LUTHERANS4.98%
BlackRock, Inc.1.81%
WEXFORD CAPITAL LP1.19%
UBS Group AG1.15%
FourWorld Capital Management LLC1.06%
FLPUTNAM INVESTMENT MANAGEMENT CO0.98%
AQR CAPITAL MANAGEMENT LLC0.67%
GSA CAPITAL PARTNERS LLP0.60%
CenterBook Partners LP0.56%

Funds

Fund% owned
iShares Russell 2000 ETF0.78%
VANGUARD EXTENDED MARKET INDEX FUND0.41%
Fidelity Extended Market Index Fund0.18%
Schwab U.S. Small-Cap ETF0.16%
Fidelity Small Cap Index Fund0.15%
iShares Russell 2000 Growth ETF0.13%
Ultra-Small Company Market Fund0.13%
Saba Capital Income & Opportunities Fund0.09%
TIFF MULTI-ASSET FUND0.09%
VANGUARD RUSSELL 2000 INDEX FUND0.08%

OakChart. AIRS. Cached 15 minutes.